Skip to main content
. 2023 Apr 1;37(4):531–540. doi: 10.1007/s40259-023-00593-7

Table 1.

Variation in biosimilar coverage by included health plans

Health plan Payer size Serviced by one of the Big Three PBMsa Coverage policies, N Coverage no more restrictive than the reference product, N (%) Coverage more restrictive than the reference product, N (%)
Aetna National Yes 76 54 (71.1) 22 (29.0)
Anthem National No 55 37 (67.3) 18 (32.7)
BCBSFL Regional No 73 63 (86.3) 10 (13.7)
BCBSMA Regional Yes 75 73 (97.3) 2 (2.7)
BCBSMI Regional Yes 60 57 (95.0) 3 (5.0)
BCBSNC Regional No 72 64 (88.9) 8 (11.1)
BCBSNJ Regional No 76 74 (97.4) 2 (2.6)
BCBSTN Regional Yes 66 50 (85.5) 16 (24.2)
CareFirst Regional Yes 66 42 (63.6) 24 (36.4)
Centene National No 68 68 (100.0) 0 (0.0)
Cigna National Yes 76 76 (100.0) 0 (0.0)
Emblem Regional Yes 64 39 (60.9) 25 (39.1)
HCSC National No 60 43 (71.7) 17 (28.3)
Highmark Regional No 76 59 (77.6) 17 (22.4)
Humana National No 76 41 (54.0) 35 (46.1)
IndepBC Regional No 66 39 (59.1) 27 (40.9)
United National Yes 76 73 (96.1) 3 (4.0)
Total 1181 952 (80.6) 229 (19.4)

Payer size and PBM servicing data were retrieved from the respective health plans’ websites in December 2022. Percentages may not add up to 100% due to rounding

PBM pharmacy benefit manager

aThe Big Three included CVS Caremark, Express Scripts, and OptumRx